While there are already restrictions on the prescribing of cancer drugs in China, oncologists in the world’s second-largest pharma market are also now being expected to strictly avoid off-label use, especially of costly imported therapies from multinationals.

A national stockpile could provide immediate relief in the case of shortages, but also a ‘floor’ under pricing that might prevent more shortages in the first place, the head of the US FDA’s Oncology Center of Excellence says.

House Republicans keep pressure on US FDA for plans to catch up on inspections after long COVID-19 hiatus. Recent cancer drug shortages could be a headline event to lead into larger probe.

House Republicans keep the pressure on the US FDA for plans to catch up on inspections after the long COVID-19 hiatus. Recent cancer drug shortages could be a headline event to lead into a larger probe.